So you’re living in the UK and
dream of giving your dog’s genes a chance to live on in a cloned body? One
South Korean firm is willing to offer a 70 per cent discount if you pose for
the cameras and are not expecting them to copy the personality too.
The firm, Sooam Biotech, has been
commercially cloning pets for years, with the majority of its customers coming
from the US. The task is currently priced at $100,000, but the winner will
receive a considerable slash from that tag. Contenders are encouraged to send a
500-word essay along with photos, videos of up to 5 minutes, and other material
explaining why their dog should be cloned.
There are no restrictions on the
breed, sex, size or age of the dog, but the winner must be prepared for the
media appearances that would come into his or her life, along with the furry
clone. Submissions are accepted until July 1.
The cloning technology itself is
following the well-established routine. Sooam researchers will extract DNA from
a viable skin cell taken from the dog and implant it into another dog’s egg
cell, which had been cleared of DNA beforehand. The resulting embryo will then
be implanted into a surrogate mother, which will give birth to a cloned puppy
some two months later.
The South Korean firm is headed by
controversial researcher Hwang Woo-suk, who rose to notoriety after falsifying
research data in his 2004 study of human embryotic stem cells. Sooam was among
the pioneers of dog cloning and also successfully cloned other canines, such as
wolves and coyotes. Last year it announced its plans to recreate a woolly
mammoth by extracting the extinct animal’s DNA from frozen samples and
incubating an embryo in an elephant surrogate mother.
Pet cloning remains an
ethically-controversial and niche business. Critics say that rich people who
spend thousands of dollars on cloning their pets should instead help animal
shelters and adopt a new pet from one of those. There is also the implication
that cloning firms are misleading their clients, because the technology can
offer replication of the body, while the behavior of the cloned pet may differ
markedly from that of the original.
"I think that personality is
really what most people are looking to clone," John Woestendiek, a dog
cloning investigator and author, told Live Science. "And I don't think
personality is clone-able."
Pet cloning may enjoy high media
attention, but the market for it is surprisingly small, according to BioArts
International, a US-based company that outsourced pet cloning to Sooam Biotech
before going out of business in 2009.
Just like Sooam in UK, BioArts
promoted its services in America with a 2008 competition offering free cloning.
It received 237 applications, the firm said, eventually awarding the privilege
to a rescue dog which had reportedly found the last survivor of the 2001
terrorist attack in New York.
